Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Daily News

Closing the Left Atrial Septal Pouch For Stroke Prevention Explored in Small Trial

Todd Neale

November 25, 2024

Presentation TCT 2024

M-TEER in SMR: Device Selection, Procedural Considerations, and How to Define Success

Presenter: Saibal Kar

October 29, 2024

Presentation TCT 2024

The Most Interesting ‘M-TEER in SMR’ Studies of 2024

Presenter: Gregg Stone

October 29, 2024

Presentation TCT 2024

What Every Cardiologist Should Know About the Management of Heart Failure

Presenter: James Udelson

October 29, 2024

Presentation TCT 2024

How To Select the Most Appropriate SMR Patients For M-TEER?

Presenter: JoAnn Lindenfeld

October 29, 2024

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Caitlin E. Cox

October 03, 2024

News Conference News ESC 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

Shelley Wood

September 01, 2024

News Daily News

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Shelley Wood

July 09, 2024

News Conference News NY Valves 2024

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Michael O'Riordan

June 10, 2024

Presentation NY Valves 2024

CON: TMVR Has too Many Problems – Just Do M-TEER

Presenter: Saibal Kar

June 06, 2024

Presentation NY Valves 2024

PRO: TMVR Is a Good Option for Functional MR

Presenter: Chet Rihal

June 06, 2024

Presentation NY Valves 2024

Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show?

Presenter: Javed Butler

June 06, 2024

Presentation NY Valves 2024

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

Presenter: Michael Joseph Rinaldi

June 06, 2024

Presentation NY Valves 2024

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

Presenter: JoAnn Lindenfeld

June 06, 2024

Presentation NY Valves 2024

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Presenter: Anna Sannino

June 06, 2024

Presentation NY Valves 2024

Secondary MR and GDMT Titration Before M-TEER in the Real-world

Presenter: Donna Mancini

June 05, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

Advertisement

Closing the Left Atrial Septal Pouch For Stroke Prevention Explored in Small Trial

M-TEER in SMR: Device Selection, Procedural Considerations, and How to Define Success

The Most Interesting ‘M-TEER in SMR’ Studies of 2024

What Every Cardiologist Should Know About the Management of Heart Failure

How To Select the Most Appropriate SMR Patients For M-TEER?

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

CON: TMVR Has too Many Problems – Just Do M-TEER

PRO: TMVR Is a Good Option for Functional MR

Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show?

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Secondary MR and GDMT Titration Before M-TEER in the Real-world

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content